BENJAMIN DAHUNSI: Open Payments
NPI 1225535206 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 26 payments from 10 companies in 2025. Trend: 2023 $1,966 · 2024 $1,203 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $119 |
| Almatica Pharma LLC | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Alkermes, Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Lundbeck LLC | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| ABBVIE INC. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: Auvelity, LOREEV XR, TRINTELLIX, ARISTADA, INGREZZA, COBENFY, VRAYLAR, INVEGA SUSTENNA.
Industry payments across MD — which companies pay providers there.
